Facebook Join My List Logo
American Society of Interventional Pain Physicians | September 18, 2019
1-Day Passes Available for Midsouth Meeting in Memphis This Week!
 
The inaugural Midsouth Societies of Interventional Pain Physicians begins this Friday in Memphis at the Historic Peabody Hotel.
 
You may register online or onsite for the full meeting or for a 1-Day pass. Click here for meeting pre-registration.
 
IPM: Issues, Pitfalls and Opportunities is for physicians and midlevel practitioners for the following states: Alabama, Arkansas, Indiana, Kentucky, Mississippi, Missouri, and Tennessee.
 
The meeting will address regulatory aspects of opioid therapies while also bringing in the DEA’s perspective. Learn about advances in the field and bring your staff for sessions on billing and coding and denials and appeals.
 
CATEGORY I CREDIT
The Institute for Medical Studies designates the Midsouth 2019 Annual Meeting live activity for a
maximum of 17 AMA PRA Category 1 Credits™ .
 
Click Below to view:
Join the AMA to help us keep our seat in the House of Delegates

The American Medical Association (AMA) requires all societies to requalify for membership in the AMA House of Delegates (HOD) every five years. In order for ASIPP to retain our seat, the AMA requires that 20% of ASIPP’s physician members also be members of the AMA. Unfortunately, ASIPP is at risk of losing representation in the AMA because we have fallen below the 20% membership minimum threshold.

Membership in the AMA gives us a voice in shaping policy that affects our practice and patients.
We encourage you to join or renew your membership in the AMA. Joining the AMA will further strengthen our specialty’s representation at the national level through the AMA House of Delegates, the AMA’s policymaking body, and strengthen our ability to meet the challenges in health care today with thoughtful, well-organized responses.

We strongly encourage you to join the AMA today to help us keep our seat at the table. Right now, you can become a member and pay only half the dues.

The stronger our membership, the more we can advance issues that are important to our specialty including improving the Medicare Quality Payment Program, reducing administrative burdens and ensuring accurate coding and reimbursement of our services.

Thank you for supporting ASIPP!

Click HERE to join today and pay only half price! 
OxyContin Maker Purdue Pharma Files for Bankruptcy Protection

Purdue Pharma LP filed for bankruptcy protection Sunday night with a  partial deal  aimed at resolving thousands of lawsuits filed by states and municipalities accusing it of fueling the opioid crisis.

The filing, made in federal bankruptcy court in White Plains, N.Y., marks a remarkable downfall for the closely held company started more than five decades ago in New York by three physician brothers. After it launched the prescription opioid OxyContin in the 1990s, Purdue became one of the most recognizable names in treating pain, a characteristic that later helped make it a target for blame for the opioid crisis.

Purdue faces lawsuits from virtually every state, as well as some 2,600 cities, counties, Native American tribes, hospitals and others seeking to recoup costs incurred from opioid addiction. The Justice Department also has  civil and criminal probes  into the company.
 
Access to this article may be limited.
DEA logo
DEA Proposes Less Opioid Production, More Marijuana for Research in 2020

The Drug Enforcement Administration (DEA) is proposing a reduction in the amount of Schedule II controlled substances that can be manufactured in the US next year.

According to the Notice of Proposed Rulemaking , the DEA proposes the following cuts in opioid production:

  • 31% reduction of fentanyl
  • 19% reduction of hydrocodone
  • 25% reduction of hydromorphone
  • 9% reduction of oxycodone
  • 55% reduction of oxymorphone

JUNE 2020 ABIPP EXAMS
AND COMPETENCY EXAMS
June 13 - June 14, 2020 | Memphis, TN
 
The American Board of Interventional Pain Physicians ( ABIPP ) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
ABIPP now offers the only competency certification program for regenerative medicine.
 
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
 
June 13
ABIPP Part I  
Combined CSM/CCPM Exam for ABIPP Path
Competency Exam in Controlled Substance Management
Competency Exam in Coding, Compliance, and
Practice Management

June 13-14
ABIPP Part II  
Regenerative Medicine Competency Exam
Endoscopic Lumbar Decompression Competency Exam

June 14
ABIPP Competency Exam


939 Ridge Lake Blvd. | Memphis, TN 38120
 
Docs Want Say in How Prior Authorizations Work
"You would have much greater buy-in from physicians," House panel told

 
WASHINGTON -- Practicing doctors should have input when it comes to deciding how prior authorization processes should work, an expert told members of a House committee on Wednesday.

"Instead of pharmacy benefit managers deciding on how best to administer prior authorizations, have the physicians who are at the point of the spear weigh in," said Howard Rogers, MD, PhD, of Norwich, Connecticut, speaking on behalf of the American Academy of Dermatology (AAD). "The AAD would love to have seat at the table in terms of defining what's reasonable in terms of different treatment algorithms, and you would have much greater buy-in from physicians if we could have that sort of collaborative arrangement." Rogers spoke at a House Small Business Committee hearing on the burdens to physician practices posed by prior authorization and step therapy.
 
Use of Pain Reliever Tramadol May Up Risk for Hypoglycemia

HealthDay News — Use of the widely prescribed opioid tramadol is associated with a greater risk for developing hypoglycemia compared with almost every other opioid, according to a study published online Aug. 28 in Scientific Reports .

Tigran Makunts, Pharm.D., from the University of California in San Diego, and colleagues analyzed more than 12 million reports from the U.S. Food and Drug Administration Adverse Event Reporting System to assess adverse reactions associated with tramadol. The authors also evaluated adverse events for other widely prescribed opioids and similar-acting, nonopioid medications, such serotonin-norepinephrine reuptake inhibitors and drugs affecting the activity of N-methyl-D-aspartate receptors.

Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

2019 MIPS Reporting? Start Now.
MIPS-eligible clinicians must report a full year of data. Don’t fall behind – keep up with NIPM-QCDR.
 
MIPS 2019 has brought larger payment adjustments and greater reporting requirements, including a 365-day performance period for the Quality and Cost categories. The sooner you start your MIPS reporting for 2019, the better.
Sign up today to use ASIPP’s NIPM-QCDR for MIPS.
This powerful tool makes MIPS reporting easy through the use of our new patient-reported outcomes measures for 2019, which ease the burden on providers and reduces costly EMR integration.

Get started today at ASIPP.ArborMetrix.net

Repealing Medicaid access rule could vastly lower provider pay, say opponents
 
Provider and patient advocacy groups urged the CMS to rescind its proposed repeal of the Medicaid access rule , arguing that it would reduce access to care and create financial hardship for both beneficiaries and providers.

The current Medicaid access rule requires states to monitor and document fee-for-service Medicaid payments and their impact on beneficiary access to care. The CMS is proposing to repeal that rule to ease the administrative burden for states with 85% or more of their beneficiaries enrolled in Medicaid managed care. The proposed rule would allow states to reduce reimbursement rates to fee-for-service providers without having to demonstrate to the CMS that the rate reductions won't reduce access to care.

Urine Drug Tests Increasingly Positive For Nonprescribed Fentanyl

Urine drug tests (UDTs) for cocaine use are showing a significant increase in positive results for nonprescribed fentanyl, according to a cross-sectional study of test results for a nearly five-year period.

In a sampling of 1 million UDT specimens, verified nonprescribed fentanyl among the cocaine-positive samples rose from 0.9% in 2013 to 17.6% in 2018, for an increase of 1,850%.

Although not as dramatic, positivity rates for nonprescribed fentanyl in the methamphetamine-positive group also increased significantly during the same time period, from 0.9% to 7.9%, for a 798% increase.

The Opioid Crisis Is Not About Opioids

Ultimately the “opioid crisis” is not about opioids, it is about addiction and mental health and societal despair. In fact, the majority of drug overdose deaths are due to multiple substances, including alcohol and benzodiazepines, not just opioids. The real crisis we are facing in this country is a substance abuse problem, not an opioid abuse problem.

The hysteria around opioid use for chronic pain is wrong and not supported by the facts. Studies show that among people who are prescribed opioids, addiction is relatively uncommon. According to a brilliant article by Dr. Sally Satel, “the percentage of patients who become addicted after taking opioids for chronic pain is measured in the single digits; studies show an incidence from less than 1 percent to 8 percent.”

It is important here to clarify the difference between addiction and dependence. Because of how opioids affect the brain, anyone taking this type of medications regularly will develop physical dependence on them, meaning if the medications are stopped suddenly withdrawal symptoms may occur. Dependence is not the same as addiction. Addiction means abnormal behaviors around a medication, using it to change your mood or get high, and being unable to control your use of the medication

Texas Health Care Fraud and Opioid Takedown Results in Charges Against 58 Individuals

The Justice Department announced today a coordinated health care fraud enforcement operation across the state of Texas, involving charges against a total of 58 individuals across all four federal districts in Texas for their alleged involvement in Medicare fraud schemes and networks of “pill mill” clinics resulting in $66 million in losses and 6.2 million pills. Of those charged, 16 were doctors or medical professionals, and 20 were charged for their role in diverting opioids.  
 
Today’s enforcement actions were led and coordinated by the Health Care Fraud Unit of the Criminal Division’s Fraud Section in conjunction with its Medicare Fraud Strike Force (MFSF) partners. The MFSF is a partnership among the Criminal Division, U.S. Attorney’s Offices, the FBI, Health and Human Services-Office of Inspector General (HHS-OIG) and the Drug Enforcement Administration (DEA). In addition, the operation includes the participation of the Veterans Affairs-OIG, the Department of Labor and various other federal law enforcement agencies and Texas State Medicaid Fraud Control Units.  

The charges announced today aggressively target schemes billing Medicare, Medicaid, TRICARE (a health insurance program for members and veterans of the armed forces and their families), Department of Labor-Office of Worker’s Compensation Programs, and private insurance companies for medically unnecessary prescription drugs and compounded medications that often were never even purchased and/or distributed to beneficiaries. The charges also involve individuals contributing to the opioid epidemic, with a particular focus on medical professionals allegedly involved in the unlawful distribution of opioids and other prescription narcotics, a particular focus for the Department. 
 
DOJ

State Society News 
October 25-27, 2019
CalSIPP

California Society of Interventional Pain Physicians 10 th annual meeting
The Resort at Squaw Creek, Lake Tahoe.
 



Send in your state society meeting news to Holly Long, hlong@asipp.org
ASIPP | Pain Physician Journal | Phone | Fax | Email